Novavax (NVAX) Says Phase I Results in RSV Development Program Similar to Preclinical Data

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/18/2026

1. NVDA
2. DOO
3. ARGX
4. HD
5. METC
6. SPY
7. FN
8. TSLA
9. XP
10. SNOW

Go back to Novavax (NVAX) Says Phase I Results in RSV Development Program Similar to Preclinical Data
Novavax, Inc. (NASDAQ: NVAX) Delayed: 7.88 -0.19 (2.35%)
Previous Close $8.07    52 Week High $9.23 
Open $7.97    52 Week Low $1.16 
Day High $8.08    P/E N/A 
Day Low $7.84    EPS $-0.30 
Volume 612,559